Medicine and Dentistry
Nanoparticle
100%
Traumatic Brain Injury
63%
Monocyte
45%
Macrophage
36%
Immunocompetent Cell
27%
Cells
27%
Therapeutic Procedure
27%
Chemokine
18%
Microglia
18%
Edema
18%
Receptor
18%
Injury
18%
Combination Therapy
18%
Clinical Trial
13%
Cytokine Release
9%
Cell Type
9%
Gliosis
9%
Polyglactin
9%
Motor Performance
9%
Serositis
9%
Intravenous Drug Administration
9%
Gene Expression
9%
Cytokine
9%
Stem Cell
9%
Vision
9%
Brain Tissue
9%
Brain
9%
Spleen
9%
Epithelial Mesenchymal Transition
9%
Survival
9%
Health
9%
Chlormethine
9%
Emergency
9%
INIS
nanoparticles
100%
injuries
81%
brain
81%
monocytes
45%
macrophages
36%
inflammation
27%
therapy
18%
cytokines
18%
edema
18%
preservation
18%
receptors
18%
glycolic acid
9%
levels
9%
genes
9%
tissues
9%
spleen
9%
damage
9%
administration
9%
travel
9%
temperature range 0273-0400 k
9%
clinical trials
9%
oxygen
9%
particles
9%
interventions
9%
humans
9%
motors
9%
emergencies
9%
Immunology and Microbiology
Immunity
100%
Monocyte
45%
Cells
45%
Immunocompetent Cell
27%
Microglia
18%
Gene Expression
9%
Glycolic Acid
9%
Lineages
9%
Cytokine Release
9%
Room Temperature
9%
Vision
9%
Brain Tissue
9%
Brain
9%
Inflammation
9%
Health
9%
Survival
9%